Daily BriefsPrivate Markets

Daily Brief Private Markets: Marshall Wace Bets $30m in Singapore’s Thunes and more

In today’s briefing:

  • Marshall Wace Bets $30m in Singapore’s Thunes
  • Thai Insurtech Firm Roojai Bags US$42M in Fresh Funding
  • Right-Hand Cybersecurity Raises US$5M Series A for Asia, US Expansion
  • B2B Life Sciences Marketplace Labviva Secures US$20M Series A
  • Qoala Raises Another $7.5m, Targets Profitability in 3 Years

Marshall Wace Bets $30m in Singapore’s Thunes

By Tech in Asia

  • Thunes, a global cross-border payments firm headquartered in Singapore, has raised US$30 million from London-based hedge fund Marshall Wace, according to VentureCap Insights, which tracks regulatory filings in the city-state.
  • Peter de Caluwe, CEO of Thunes, has confirmed to Tech in Asia that Marshall Wace is the new investor.
  • The funding brings the company closer to becoming a billion-dollar company, with an estimated post-money valuation now pegging at US$776 million after raising about US$166 million in equity funding.

Thai Insurtech Firm Roojai Bags US$42M in Fresh Funding

By e27

  • Thai insurtech company Roojai has secured US$42 million in new financing round, as per multiple news reports.
  • HDI International, a subsidiary of Germany’s Talanx Group, led the round that also saw participation from existing investor IFC.
  • About US$32 million will be invested via direct injection and the remaining amount through a secondary share transaction.

Right-Hand Cybersecurity Raises US$5M Series A for Asia, US Expansion

By e27

  • Singapore-based startup Right-Hand Cybersecurity has received US$5 million Series A funding from former PayPal executive Jack Selby and his venture capital firm AZ-VC.
  • The startup will use the money to expand its operations across Asia and the US while investing heavily in its human risk management (HRM) platform.
  • Right-Hand aims to expand its platform integrations with commonly adopted technologies to improve employee behaviours and lower risk tendencies.

B2B Life Sciences Marketplace Labviva Secures US$20M Series A

By e27

  • Labviva, a Singapore- and US-based AI-driven life sciences digital marketplace, has secured US$20 million in Series A financing led by Biospring Partners.
  • Existing investors Senator Investment Group, B Capital, and Glasswing Ventures co-invested.
  • The Series A funding brings the total amount raised since inception to US$30 million.

Qoala Raises Another $7.5m, Targets Profitability in 3 Years

By Tech in Asia

  • Indonesian insurtech startup Qoala announced that it has raised US$7.5 million in a series B extension round led by Europe’s responsAbility Investments.
  • Existing investors Eurazeo and Indogen as well as new investor AppWorks also participated in the round.
  • The startup declined to comment on its valuation, but VentureCap Insights currently pegs it at US$310 million following the fundraise.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars